Liraglutida, administrada a una dosis de 1,8mg diarios durante 48 semanas, demostr resolucin de la esteatohepatitis no alcohlica (sin empeoramiento de la fibrosis) en el 39% de los pacientes, en comparacin con el 9% con placebo, en un ensayo de fase 2 que incluy a 23 pacientes con obesidad (IMC 34,24,7kg/m2) y evidencia clnica de esta enfermedad
When considering oral Wegovy vs injection, many find the oral Wegovy effectiveness comparable, depending on individual factors such as baseline weight, adherence to prescribed regimens, dietary habits, and activity levels
Common side effects include: Nausea: This is the most reported issue for both forms
For dosing guidance, use our free tirzepatide dosage calculator or semaglutide dosage calculator
Raya, Effect of silymarin on kidneys of rats suffering from alloxan-induced diabetes mellitus, Phytomedicine , vol